Grossman Adam S 4
4 · ADMA BIOLOGICS, INC. · Filed Feb 23, 2026
Research Summary
AI-generated summary of this filing
ADMA BIOLOGICS (ADMA) CEO Adam Grossman Sells 24,793 Shares
What Happened
Adam S. Grossman, President, CEO and a director of ADMA BIOLOGICS (ADMA), had 24,793 shares of common stock withheld on February 19, 2026 at $16.32 per share to satisfy $404,622 in mandatory tax withholding related to RSU vesting. This disposition is reported as code F (tax withholding) and is not an open‑market sale.
Key Details
- Transaction date: 2026-02-19; reported on Form 4 filed 2026-02-23.
- Price: $16.32 per share; total value of withheld shares: $404,622.
- Transaction type/code: F — shares withheld to satisfy tax withholding upon RSU vesting (not an open‑market sale).
- Reported direct holdings: filing references 1,007,896 shares of common stock owned by Grossman (per filing footnote).
- Unvested equity (per footnotes): ~1,251,690 unvested RSUs across multiple grants (grants from 2022–2026) that vest quarterly over four years.
- Additional ownership: filing notes shares owned by entities Areth, LLC and Hariden, LLC for which Grossman is a control person/managing member (specific entity holdings not shown here).
- No indication in the provided data that this was a 10b5-1 plan or a late filing flag; this was a routine tax‑withholding settlement.
Context
- Code F (tax withholding) transactions are routine: when RSUs vest, companies often withhold a portion of shares to cover taxes rather than requiring cash. These are not market‑sales and generally do not signal insider sentiment the way open‑market purchases or voluntary sales might.
- The filing shows substantial remaining unvested RSUs and significant reported direct ownership, meaning Grossman retains meaningful exposure to ADMA equity despite the withholding.
Insider Transaction Report
Form 4
Grossman Adam S
DirectorPresident and CEO
Transactions
- Tax Payment
Common Stock
[F1][F2][F3][F4]2026-02-19$16.32/sh−24,793$404,622→ 2,259,586 total
Holdings
- 1,143,426(indirect: See Footnote)
Common Stock
[F5] - 580,957(indirect: See Footnote)
Common Stock
[F6]
Footnotes (6)
- [F1]Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units ("RSUs"). This is not an open market sale of securities.
- [F2]Includes, as of the transaction date, (i) 282,529 unvested RSUs granted on February 9, 2026, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (ii) 189,017 unvested RSUs out of 252,022 RSUs granted on February 19, 2025, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting;
- [F3](continued from footnote 2) (iii) 418,296 unvested RSUs out of 557,728 RSUs granted on February 26, 2024, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (iv) 286,848 unvested RSUs out of 573,695 RSUs granted on March 6, 2023 that will vest quarterly on each annual anniversary of the date of grant, over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting;
- [F4](continued from footnote 3) (v) 75,000 unvested RSUs out of 300,000 RSUs granted on March 7, 2022 that will vest quarterly on each annual anniversary of the date of grant, over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; and (vi) 1,007,896 shares of common stock owned by the Reporting Person, which reflects prior purchases and the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes.
- [F5]These shares are owned by Areth, LLC ("Areth"). The Reporting Person is a control person of Areth.
- [F6]These shares are owned by Hariden, LLC ("Hariden"). The Reporting Person is the managing member of Hariden.
Signature
/s/ Adam S. Grossman, by Michael A. Goldstein as Attorney-in-fact|2026-02-23